Vornorexant, also known by its developmental code names ORN-0829 and TS-142, is an orexin antagonist medication which is under development for the treatment...
6 KB (390 words) - 00:26, 3 January 2024
development reported for anxiety disorders and panic disorder, up to phase 2 Vornorexant (ORN-0829, TS-142) – dual OX1 and OX2 antagonist – under development...
20 KB (2,071 words) - 07:21, 31 October 2024
fatigue, dizziness, headache, abdominal discomfort, and nightmares. Vornorexant – another investigational short-acting orexin receptor antagonist List...
7 KB (498 words) - 08:59, 15 September 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
54 KB (6,141 words) - 02:00, 22 September 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
5 KB (301 words) - 01:41, 22 September 2024
earlier phases of elimination. The investigational agents seltorexant and vornorexant, which are still in clinical trials, have comparatively very short half-lives...
94 KB (8,941 words) - 16:56, 16 September 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
4 KB (194 words) - 22:13, 5 November 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
6 KB (408 words) - 01:39, 31 October 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
21 KB (1,687 words) - 09:07, 5 September 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
5 KB (235 words) - 21:40, 6 November 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
8 KB (532 words) - 01:59, 22 September 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
47 KB (4,026 words) - 18:21, 15 November 2024
(MIN-202, JNJ,42847922, JNJ-922) – selective OX2 receptor antagonist [4] Vornorexant (ORN-0829, TS-142) – dual OX1 and OX2 receptor antagonist [5] Piromelatine...
6 KB (304 words) - 22:38, 30 October 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
5 KB (653 words) - 05:33, 8 December 2023
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
5 KB (272 words) - 04:50, 24 October 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
8 KB (670 words) - 16:12, 17 October 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
3 KB (122 words) - 10:17, 10 November 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
2 KB (154 words) - 16:45, 7 November 2022
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
3 KB (131 words) - 02:27, 8 May 2023
antagonist Suvorexant (Belsomra) – dual OX1 and OX2 receptor antagonist Vornorexant (ORN-0829, TS-142) – dual OX1 and OX2 receptor antagonist ACT-335827...
14 KB (1,338 words) - 06:21, 7 October 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
3 KB (202 words) - 22:18, 23 September 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
3 KB (173 words) - 16:49, 30 September 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
3 KB (133 words) - 14:51, 22 January 2023
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
5 KB (363 words) - 15:20, 7 September 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
8 KB (606 words) - 16:15, 31 March 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
10 KB (1,104 words) - 02:20, 10 March 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
17 KB (1,672 words) - 02:28, 15 August 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
10 KB (996 words) - 21:32, 22 January 2024
SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925)...
3 KB (158 words) - 21:33, 22 January 2024